NeuroVive Pharmaceutical AB Company Profile | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | NeuroVive Pharmaceutical AB

NeuroVive Pharmaceutical AB

NeuroVive Pharmaceutical AB
Stock Exchange	Other OTC
EPS	$0.09
Market Cap	$25.1 M
Shares Outstanding	52.33 M
Public Float	-

NeuroVive Pharmaceutical AB
Stock Exchange	Frankfurt Stock Exchange
EPS	-
Market Cap	-
Shares Outstanding	91.57 M
Public Float	-

NeuroVive Pharmaceutical AB
Stock Exchange	OTC Publication Venue
EPS	SEK0.78
Market Cap	SEK228.72 M
Shares Outstanding	185.95 M
Public Float	-

Profile

Address	Medicon Village Lund SN 223 81 Sweden
Employees	-
Website	http://www.neurovive.com
Updated	07/08/2019
NeuroVive Pharmaceutical AB engages in the research and development of pharmaceuticals that protect mitochondria from death post acute traumatic injury. The company was founded by Eskil Elmer on February 1, 2000 and is headquartered in Lund, Sweden. .

Financials

David Laskow-Pooley

Chairman

Denise Goode

Director